Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
1–21
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
children 1-21 years of age
confirmed diagnosis of measurable solid tumor, including brain tumor, which has progressed on or after standard therapy, or for which no effective standard therapy is known
at least 4 weeks since last dose of immunotherapy, radiotherapy, or chemotherapy
no more than 3 prior chemotherapies
no symptomatic brain metastases
Clareo Health | A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors
